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A B S T R A C T
Background
Vital registration and cause of death reporting is incomplete in the countries in which the HIV
epidemic is most severe. A reliable tool that is independent of HIV status is needed for
measuring the frequency of AIDS deaths and ultimately the impact of antiretroviral therapy on
mortality.
Methods and Findings
A verbal autopsy questionnaire was administered to caregivers of 381 adults of known HIV
status who died between 1998 and 2003 in Manicaland, eastern Zimbabwe. Individuals who
were HIV positive and did not die in an accident or during childbirth (74%; n ¼ 282) were
considered to have died of AIDS in the gold standard. Verbal autopsies were randomly
allocated to a training dataset (n¼ 279) to generate classification criteria or a test dataset (n¼
102) to verify criteria. A rule-based algorithm created to minimise false positives had a
specificity of 66% and a sensitivity of 76%. Eight predictors (weight loss, wasting, jaundice,
herpes zoster, presence of abscesses or sores, oral candidiasis, acute respiratory tract infections,
and vaginal tumours) were included in the algorithm. In the test dataset of verbal autopsies,
69% of deaths were correctly classified as AIDS/non-AIDS, and it was not necessary to invoke a
differential diagnosis of tuberculosis. Presence of any one of these criteria gave a post-test
probability of AIDS death of 0.84.
Conclusions
Analysis of verbal autopsy data in this rural Zimbabwean population revealed a distinct
pattern of signs and symptoms associated with AIDS mortality. Using these signs and
symptoms, demographic surveillance data on AIDS deaths may allow for the estimation of AIDS
mortality and even HIV prevalence.
The Editors’ Summary of this article follows the references.
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Introduction
UNAIDS estimates that 24.5 million people in sub-Saharan
Africa were living with HIV by 2005. The estimated annual 2.0
million AIDS-related deaths in sub-Saharan Africa in 2005
represent a dramatic impact on patterns of adult mortality
[1]. However, direct assessment of the level and causes of
mortality is not possible in the majority of high-mortality
countries, because vital registration and cause of death
reporting is incomplete or absent [2,3].
The demand for accurate data on levels and trends in AIDS
mortality is increasing. Mortality statistics are an important
advocacy tool and, in the era of antiretroviral therapy (ARV),
the documentation of trends in AIDS mortality becomes even
more important, as has been shown in the developed
countries [4,5]. AIDS mortality in the population needs to
be measured in order to evaluate the effectiveness of ARV
scale-up as well as programmes to treat opportunistic
infections [6].
In the absence of vital registration, data on the levels and
trends of AIDS mortality in the general population are
derived from health facilities, special population-based
studies (e.g., demographic surveillance systems). Mortuary
studies [9,10] and burial record surveillance [11] are addi-
tional sources of AIDS mortality that have been used in some
countries. Mortality records from hospitals are generally not
a reliable indicator of population mortality trends by cause
because of low utilization and the likelihood of changes in
utilization patterns over time. Clinical cohorts of people
living with HIV/AIDS are adequate to assess the impact of
survivorship in enrolled patients, but the effects in the wider
community may differ due to poor adherence to regimes,
inequitable access to ARV, and/or bias in selection of clinical
cohorts. Therefore, tools are required urgently that will
adequately assess the impact of ARV drugs in the population;
in this context an improved means for ascertaining AIDS
deaths is essential [7].
Demographic surveillance systems provide valuable infor-
mation on trends in age- and sex-speciﬁc mortality [8], and
may also include interviews with the relatives of the
deceased—referred to as verbal autopsy—to ascertain a
probable cause of death. HIV serostatus of the deceased
individual is, however, often unavailable, and a reliable tool,
with known sensitivity and speciﬁcity, would allow estimation
of the level of AIDS mortality in populations with unknown
serostatus.
The World Health Organisation has recognised the value of
the verbal autopsy (VA) in settings lacking vital registration,
and has called for validation studies for the VA tool in
general, as well as for speciﬁc causes [7]. Validation studies
typically compare assigned cause of death from VAs to
hospital records. However, hospital records may be a poor
reference standard for AIDS in communities where the
deceased and their caregivers are often unaware of HIV
status, a social stigma surrounds AIDS [12], hospital utiliza-
tion is limited, treatment sources are traditional, or home-
based care is widely used. The fact that contact with the
health services is the inclusion criteria for the validation
study is likely to have a major effect on the results.
The Manicaland HIV/STD Prevention Project eastern
Zimbabwe, where the HIV serostatus of individuals is known
prior to death, provides a unique opportunity to identify the
signs and symptoms differentially associated with AIDS
deaths in the pre-ARV era. Verbal autopsy data along with
HIV status are used to explore a method of creating a
diagnostic algorithm and assessing its performance.
Methods
Study Population, Mortality Surveillance, and
Administration of the Verbal Autopsy Questionnaire
The Manicaland Project includes a population-based open
cohort study of four subsistence farming areas, two roadside
trading centres, four forestry, tea and coffee estates, and two
small towns in the rural province of Manicaland in eastern
Zimbabwe [13]. A baseline survey took place from 1998 to
2000, with follow-up occurring three years later in each site.
Testing for presence of HIV antibody at baseline was
performed on dried blood spots [14]. HIV prevalence was
15% for males (aged 17–44 y) and 21% for females (15–44 y)
at baseline [15]. Male (17–54 y) and female (15–44 y) local
residents in a baseline household census were considered
eligible for the study. The study team identiﬁed deaths
through the use of checklists of all individuals interviewed at
baseline and discussions with village health workers, employ-
ers, and surviving household members present at follow-up.
When a death was ascertained, a nurse conducted an
interview using a structured verbal autopsy questionnaire
with the primary caregiver prior to death. If that person was
unavailable, a kin, a neighbour, or community health worker
was interviewed. Based on the frequency of missing responses,
primary caregivers (n ¼ 180) did not provide more complete
interviews than other respondents (n ¼ 201). Data were
collected on the signs, symptoms, and circumstances preced-
ing death using a structured, closed, interviewer-led ques-
tionnaire (Protocol S1). The verbal autopsy questionnaire was
based on one previously developed in Tanzania [16]. The
questionnaire was translated into Shona, the predominant
local language, and back-translated into English. Interviewers
were certiﬁed nurses who were trained by a lead nurse in how
to administer the verbal autopsy questionnaire. Data were
entered into an SPSS for DOS database.
Analysis
Gold standard of AIDS deaths. For the purposes of the gold
standard, we deﬁned an AIDS death as an individual who was
(a) HIV positive at baseline survey based on antibody testing
and (b) was not reported to have suffered major injury from
motor vehicle accident, injury that was self-inﬂicted (suicide),
or that was accidentally (accident) or deliberately inﬂicted by
another person (homicide) in the two weeks prior to death.
For females, direct obstetric deaths—deﬁned as (a) death
shortly before delivery, with excessive bleeding and/or severe
headaches, or (b) death during childbirth—were classiﬁed as
being non-HIV-associated. This categorisation scheme is
justiﬁed because (a) mortality rates in HIV-positive individ-
uals are nine and ten times higher in males and females,
respectively, in this population [17] and (b) preliminary
analyses demonstrated that childbirth-associated deaths were
proportionally more common in deaths amongst HIV-
negative women (6%; n ¼ 3) than those of HIV-positive
women (2%, n¼ 3), as has been observed in other studies [9].
Misclassiﬁcation in the gold standard was estimated by
applying the underlying hazard of death (mortality rate in
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HIV-negative population) to the HIV-positive population, and
then subtracting the ‘‘observable’’ misclassiﬁcations from
obstetric and accident/injury deaths. Given the high sensitivity
and speciﬁcity of the HIV-1 antibody diagnostic dipstick [14]
and the very low probably of AIDS death occurring within
three years of infection, we assumed no misclassiﬁcation of
individuals who were HIV negative at baseline.
Train and test datasets. Two datasets were created from all
deaths for which full information was available for analysis.
The ﬁrst dataset (train) was used to create the diagnostic
algorithm, as described below. The algorithm was then
applied to the second dataset (test), in order to evaluate
how accurately deaths were classiﬁed. Each case had an
independent chance (0.75:0.25) of being assigned to the train
or test dataset. A random number ranging from 0 to 1.0 was
generated for each case; cases with a number 0.75 or lower
were assigned to the train dataset
Construction of the ‘‘diagnostic’’ algorithm. The strength of
association of a range of clinically relevant signs and
symptoms with the outcome of AIDS death was measured
by calculation of the likelihood ratio (LR), where LR ¼
sensitivity / (1 – speciﬁcity). Each sign and/or symptom with a
LR of 1.92 (corresponding to a signiﬁcant v2 test on 1 degree
of freedom at p , 0.05) or greater was retained for further
analysis. The focus of the algorithm was on speciﬁcity because
(a) we knew a priori that most adult deaths were HIV-
associated and (b) we wanted to err conservatively by avoiding
false positive results. The classiﬁcation algorithm was then
constructed with signs/symptoms added stepwise in an
iterative process. First, the sign/symptom with the highest
speciﬁcity for AIDS deaths was identiﬁed. All deaths with this
symptom present were then classiﬁed as AIDS-associated. The
speciﬁcity of all the remaining signs/symptoms were then
recalculated using only those cases not classiﬁed as AIDS-
associated based on a previously included sign/symptom. This
procedure was repeated until all criteria were added stepwise.
Analysis of the diagnostic algorithm. In order to visualise
the trade-off between increasing sensitivity and decreasing
speciﬁcity with each additional sign/symptom, modiﬁed
receiver operator characteristic (ROC) curves were plotted.
(The plots are ‘‘modiﬁed’’ in that traditional ROCs display
different cut-off points of a single parameter in the same
model: here we are using a ‘‘lower cut-off’’ by adding less-
speciﬁc criteria to the algorithm.) The best cut-off value from
the modiﬁed ROC curve was selected by choosing the point
closest to the upper left hand-corner of the plot.
In order to assess the reliability of the classiﬁcation scheme,
we examined associations between characteristics of the
verbal autopsy procedure, the respondents, or the deceased,
and the proportion correctly classiﬁed. Logistic regression
models were ﬁtted using ‘‘correctly classiﬁed’’ (Y/N) as the
dependent variable.
Post-test probability. In this study, post-test probability (þ)
was the likelihood that an individual death was due to AIDS
(according to the gold standard) after the verbal autopsy
algorithm provided a positive result—that is, AIDS death. The
post-test probability was calculated with the following
formula:
PðDÞPðTþjDÞ
Pð DÞPðTþj Dþ PðDÞPðTþjDÞ; ð1Þ
where P(TþjD) is the probability of a positive test amongst
AIDS deaths; Pð DÞ is the probability of non-AIDS death; and
PðTþj DÞ is the probability of a positive test amongst non-
AIDS deaths. For this analysis, the pre-test probability, P(D),
that an individual died of AIDS was set at 0.65—the
population attributable fraction of 17- to 44-year-old mortal-
ity attributable to HIV, where the population attributable
fraction represents the proportion of all deaths that would be
averted if AIDS mortality was removed completely [17]. The
post-test probability was then updated based on the
participant meeting the criteria or not.
Results
HIV-Positive and -Negative Deaths, Randomisation, and
Classification Based on Gold Standard Criteria
A total of 404 deaths were recorded in the study period.
Verbal autopsy was not performed on 21 of these deaths and
HIV status at baseline was missing from another two deaths,
leaving 381 complete records (94%) from the total popula-
tion that died (Figure 1). Of this total, 292 (77%) were HIV
positive at baseline. Accidents or injury were the cause of
death in 18 patients, seven of whom were HIV-positive and 11
of whom were HIV-negative at baseline. As would be
expected, given the higher death rate of those HIV infected
the proportion of those dying of non-HIV-associated causes
was less in the HIV positives. The odds of accident or injury
death were lower in HIV-positive people (odds ratio [OR] ¼
0.17; 95% conﬁdence interval [CI], 0.07–0.46). Direct obstetric
causes accounted for the deaths of six women, three of whom
were HIV-positive at baseline. The odds of direct obstetric
death were lower in HIV-positive women (OR¼ 0.30; 95% CI,
0.06–1.5).
Classifying all HIV-positive non-accident/injury and non-
childbirth deaths as ‘‘AIDS deaths’’ and all others as ‘‘non-
AIDS deaths’’ gave a gold standard of 282 AIDS deaths (74%)
and 99 Non-AIDS deaths (26%).
Of the 381 deaths studied, 279 (71%) were randomly
assigned to the train dataset and 102 (29%) to the test dataset.
In the train dataset, 73% of the deaths were AIDS-associated
compared with 75% in the test dataset (v2 p ¼ 0.44).
Construction of the Algorithm
Table 1 describes the signs and symptoms that showed an
association with AIDS-deaths (LR  1.92, p  0.05). (The full
table of investigated signs and symptoms can be found in
Table S1.)
Table 2 shows the order in which criteria were added to the
algorithm and the resulting sensitivity, speciﬁcity, predictive
values, and post-test probabilities. Classifying all deaths as
HIV-associated where one or more of the ﬁrst eight criteria
(weight loss, wasting, jaundice, herpes zoster, presence of
abscesses or sores, oral candidiasis, acute respiratory tract
infections, and vaginal tumours) were present gave a
sensitivity of 71% (95% CI, 65%–77%) and a speciﬁcity of
78% (95% CI, 69%–88%) on the train dataset, correctly
classifying 73% of deaths in the train dataset. Adding a ninth
criteria (tuberculosis) resulted in a drop in speciﬁcity that was
greater than the gain in sensitivity, as shown in the ROC
curve in Figure 2. Thus the algorithm that included eight
criteria optimised the trade-off between sensitivity and
speciﬁcity.
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Applying these eight criteria to the test dataset gave a
sensitivity of 66% (95% CI, 0.56–0.77) and speciﬁcity of 76%
(95% CI, 0.59–0.93).
No statistically signiﬁcant associations were found in
logistic regression models between correct classiﬁcation and
interviewer (LR test p¼ 0.13), time between death, and VA (p
¼ 0.5), sex of the respondent (p ¼ 0.6), side of family of
respondent (p ¼ 0.5), relationship of respondent to the
deceased (p ¼ 0.5), whether the respondent was the primary
caregiver (p ¼ 0.4), or sex of the deceased (p ¼ 0.6). The
proportion correctly classiﬁed was between 0.65 and 0.81 for
all strata (Table 3).
Potential Misclassification in the Gold Standard
Given an underlying hazard of death of 7.45 per 1,000
person-years in this population [17], we would expect 30.6
deaths to occur in the HIV-positive population that were not a
result of AIDS. Ten of these deaths would have been correctly
reclassiﬁed because they were the result of observably non-
AIDS causes (obstetric or accident/injury). Therefore, we
estimate 5.4% (20.6/381) of all deaths or 7.2% (20.6/283) of
HIV-positive deaths were misclassiﬁed in the gold standard.
Prediction Based on the Algorithm
The positive predictive value using the eight criteria was
89% on the test dataset (Table 2). Because the algorithm was
constructed on speciﬁcity rather than sensitivity, the positive
predictive value exceeded the corresponding negative pre-
dictive value of 42%. Assuming a pre-test (prior) probability
of 0.65 that a death was caused by AIDS, we calculate a post-
test probability (þ) of 0.84 if the death met one of the eight
criteria of an AIDS death; the post-test probability () when
none of the eight criteria were present was 0.19.
Discussion
Analysis of verbal autopsy data in this rural Zimbabwean
population revealed a distinct pattern of signs and symptoms
associated with AIDS deaths. Using an algorithm built on
speciﬁcity that minimised false positives, an overall sensitivity
of 66% and a speciﬁcity of 76% for identifying AIDS deaths
Figure 1. Derivation of Gold Standard from HIV Serostatus at Baseline in the Train and Test Datasets
DOI: 10.1371/journal.pmed.0030312.g001
Table 1. Signs and Symptoms Predictive of AIDS-Associated Deaths
Sign Definition Based on Verbal Autopsy Question
Weight loss Moderate or severe weight lossa with no other symptoms of malnutrition
Wasting Moderate or severe weight lossa with at least four of the following symptoms: paleness, changing hair colour, oedema of legs,
burning sensations of the feet, dry scaly skin
Jaundice Acute jaundice (yellowing of the whites of the eyes during the disease that lead to death) with fever and/or itching but without
history of alcohol abuse
Herpes zoster Ever suffered from zoster
Abscesses or sores Had abscesses or sores
Oral candidiasis Had two or three of the following: ulcers in the mouth, difficulty swallowing, white patches inside the mouth and tongue
Acute respiratory tract illnessb Trouble breathing, cough lasting 3–27 d with fever but not recent TB, weight loss, or wasting, as above
Vaginal tumours Vaginal tumour for at least one month with or without bleeding
Recent TB Known to have suffered from TB in last five years
Acute diarrhoeab Loose stools lasting 3–27 d
aAs understood by respondents.
bAcute is defined as symptoms lasting up to 4 wk (27 d). Although this long period may not reconcile with other definitions of ‘‘acute,’’ it is a useful cut-off in verbal autopsy interviews
since one month is a clear recall period, see for example Quigley [26] and Todd [22].
TB, tuberculosis.
DOI: 10.1371/journal.pmed.0030312.t001
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was achieved, and this method gave similar results when
tested on a random sample of the data. These eight criteria
were selected because they maximised the trade-off between
sensitivity and speciﬁcity, while being independent of
diagnosed TB.
Differential diagnosis of AIDS and TB is difﬁcult amongst
the living; it is not surprising therefore that classiﬁcation
using verbal autopsy is problematic. TB and other opportun-
istic infections of HIV infected people share many symptoms
such as chronic cough, wasting and prolonged fever. In
Zimbabwe, an estimated 67% of all new adult TB cases are
HIV-positive and 7.5% of all AIDS deaths are due to TB [18].
One validated approach used in adult verbal autopsy study is
to classify deaths as ‘‘Tuberculosis/AIDS’’ [19]. Our VA
algorithm, which classiﬁes AIDS independently from diag-
nosed TB is suited to quantifying the direct impact AIDS
mortality in the community.
A classiﬁcation system with known sensitivity and speciﬁc-
ity has practical applications. First, the unbiased (UB)
proportion of deaths that are AIDS-associated can be
calculated as follows:
ðProportionobservedÞ  ð1 SpecificityÞ
Sensitivity ð1 SpecificityÞ ð2Þ
If we apply the observed proportion (designated P here)
from the test dataset (Ptrue positive þ Pfalse positive ¼ 0.56), we
would calculate a true proportion of AIDS deaths of 0.76
(95% CI, 0.70–0.81, calculated using the delta method) [20].
The real proportion from the gold standard was 0.74.
Furthermore, if we know the mortality rate ratio of HIV-
positive individuals with respect to the HIV-negative pop-
ulation, the HIV prevalence can be ‘‘back-calculated’’ by the
formula for proportionUB below:
Prevalencepositives3 rate ratio
ðPrevalencepositives  rate ratioÞ þ ð1 prevalencepositivesÞ
;
ð3Þ
which can be rearranged to solve for prevalencepositive:
Prevalencepositives ¼ 1Rate ratio
proportionUB
þ 1 rate ratio
: ð4Þ
Based on data from the Manicaland cohort study
(ratepositives ¼ 0.071/y; ratenegatives ¼ 0.0075/y; or rate ratio ¼
9.4) (note: similar mortality rate ratios have been observed in
other African populations with different levels of prevalence
[16,17,21–24]), we can estimate a population prevalence of
24.3% (95% CI, 18.0%–30.5%, calculated using the delta
method [Protocol S2]). The observed prevalence, which was
23.0% at baseline [25], is close to the middle of this range.
However, this calculation is presented only as an example of
the method since here the same data source is used to
estimate the input parameters (mortality rates and true
proportion of deaths) as is used for the prevalence estimate.
The accuracy of this estimation would need to be tested on
other populations, but the potential to estimate HIV
prevalence solely based on presence of signs/symptoms
surrounding death is appealing, and has potential applica-
tions in demographic surveillance systems that perform VA
but do not test for HIV. Dataset S1 contains a spreadsheet to
Table 2. Sensitivity, Specificity, Likelihood Ratio, and Ranks Based on Likelihood Ratio, Additive Specificity, and Iterative Specificity of
Selected Signs and Symptoms
Dataset Sign/Symptom Specificity
When Added
TN FN FP TP PPV NPV Correctly
Classified
PTPþ PTP
Train (n ¼ 279) 0.65a 0.35a
Weight loss 99% 73 184 1 21 95% 28% 34% 0.93 0.33
þ Wasting 95% 69 144 5 61 92% 32% 47% 0.89 0.29
þ Jaundice 99% 68 133 6 72 92% 34% 50% 0.89 0.28
þ Herpes zoster 97% 66 114 8 91 92% 37% 56% 0.88 0.25
þ Abscesses or sores 99% 65 89 9 116 93% 42% 65% 0.90 0.21
þ Oral candidiasis 95% 61 70 13 135 91% 47% 70% 0.87 0.18
þ ARTI 97% 59 62 15 143 91% 49% 72% 0.86 0.17
þ Vaginal tumours 96% 58 60 16 145 90% 49% 73% 0.86 0.17
þ Recent TB 90% 52 49 22 156 88% 51% 75% 0.83 0.15
þ Diarrhoea 51% 38 36 36 169 82% 51% 74% 0.76 0.16
Test (n ¼ 102) 0.65a 0.35a
Weight loss 25 68 0 9 100% 27% 33% 1.00 0.32
þ Wasting 23 54 2 23 92% 30% 45% 0.87 0.29
þ Jaundice 22 49 3 28 90% 31% 49% 0.85 0.28
þ Herpes zoster 22 45 3 32 91% 33% 53% 0.87 0.26
þ Abscesses or sores 20 39 5 38 88% 34% 57% 0.82 0.25
þ Oral candidiasis 19 31 6 46 88% 38% 64% 0.82 0.22
þ ARTI 19 26 6 51 89% 42% 69% 0.84 0.19
þ Vaginal tumours 19 26 6 51 89% 42% 69% 0.84 0.19
þ Recent TB 14 19 11 58 84% 42% 71% 0.76 0.19
þ Diarrhoea 13 14 12 63 84% 48% 75% 0.76 0.16
aPre-test probability.
ARTI, acute respiratory tract infection; TN, true negative, FN, false negative, FP, false positive, TP, true positive, T, test; D, disease; Se, sensitivity; Sp, specificity; OR, odds ratio, PPV, positive
predictive value; NPV, negative predictive value; PTP, post-test probability.
DOI: 10.1371/journal.pmed.0030312.t002
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calculate proportionUB, prevalencepositives, and the associated
conﬁdence intervals.
Both the sensitivity and speciﬁcity of this tool may be
considered modest. However, as the extrapolations presented
above demonstrate, for many purposes it is more important
that the characteristics of a diagnostic be known than that they
be exceptionally precise and accurate.
Other methods of creating the classiﬁcation system were
investigated; for the sake of brevity these data are not shown.
Preliminary analysis showed that these methods (LRs [similar
to above], speciﬁcity [not stepwise], and multivariable odds
ratio scoring as described by Quigley et al. [26]) were less
accurate in correctly classifying deaths as AIDS-associated.
Using different approaches, others have also used the VA
to identify AIDS deaths. Using a physician-based, rather than
algorithm-based, approach, Kamali et al. [27] achieved 92%
speciﬁcity and 92% positive predictive value of verbal
autopsy to diagnose HIV-related adult deaths in Uganda.
This highly valuable early study did not aim to devise simple
criteria, used HIV serostatus as its gold standard, and was
undertaken at a time of lower AIDS mortality. Combining a
physician and algorithm-based VA, Urassa et al. [16]
estimated that approximately half of all deaths in a
population in rural Tanzania were caused by HIV/AIDS,
although the VA was not validated within the context of their
study. In addition, in Rakai District, Uganda, Sewankambo
demonstrated the strong association of certain symptoms
with mortality in HIV-positive people, although no individual
symptom had a sensitivity greater than 40%, including the
WHO deﬁnition of AIDS at 18% [23]. We speculate that the
main reason our algorithm’s results differed from the above
studies stems from our use of a robust gold standard that
applied to all deaths in the community, rather than only those
in hospital records. Le Coeur et al. [28] also achieved
comparatively high sensitivity and speciﬁcity by using a
deﬁnition that included HIV serostatus in their reference
standard.
The WHO deﬁnition of AIDS (two or more major signs plus
one or more minor signs) was not a very accurate tool,
classifying less than half of all deaths as a result of AIDS [29].
However, the predictors of AIDS death that we identiﬁed are
largely consistent with the WHO case deﬁnition for AIDS
surveillance [29]. Weight loss, pruritic dermatitis, herpes
zoster, oropharangeal candidiasis, pneumonia (expanded
deﬁnition), and invasive cervical cancer (expanded deﬁnition)
were common to both, but more general elements of the
WHO deﬁnition (prolonged fever and chronic diarrhoea)
were not included in this algorithm.
How predictive would these eight signs and symptoms for
AIDS mortality be in other settings? In this cohort, the post-
test probability (if a death was associated with one of the eight
criteria) was 84%. If none of the criteria were met there was a
19% chance that the death was AIDS-associated. However,
these probabilities are affected by HIV prevalence and
presence of differential symptoms in non-AIDS deaths. Thus,
predictive power will be diminished in populations with
higher background levels of these signs/symptoms (e.g.,
hepatitis); however, we do not expect the signs/symptoms
used in this algorithm to be common in populations with low
levels of AIDS mortality.
Studies of diagnostic validity face the problem of ﬁnding a
suitable reference standard, and the major verbal autopsy
validation studies have used hospital records [19,30]. In this
way the VA is calibrated to attribute the same causes of death
as those recorded in hospital settings, which is the source of
many global mortality statistics, such as the ICD-10. One
other comparatively small study in rural South Africa (n ¼
109) by Hosegood et al. [31] did in fact achieve somewhat
higher sensitivity and speciﬁcity for AIDS mortality by
physician review, using hospital records as a reference
Figure 2. Modified Receiver Operator Characteristic Curves: Sensitivity
Plotted against (1  Specificity)
Datasets are train (A) and test (B). In the test dataset, no individuals were
reclassified as AIDS deaths because of presence of vaginal tumours;
therefore no data point is plotted for that criterion in (B).
DOI: 10.1371/journal.pmed.0030312.g002
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standard. However, there are two main problems with this
approach that our study may have partially overcome. First,
the populations who die in hospital in settings with poor
health infrastructure may not be representative in terms of
age, gender, or cause of death. In this study 25% of deaths
amongst HIV-positive individuals occurred in hospital
compared with 33% in HIV-negative persons (unpublished
data). Second, in places where stigma and shame are borne by
relatives of a person with AIDS, hospital records may not
reﬂect the true number of AIDS deaths. Indeed, amongst the
deaths in this study, only 71 (18%) had a death certiﬁcate, of
which 31 (62%) of HIV-positive deaths noted AIDS/HIV.
Therefore, for attribution to the single cause of AIDS, where
it is known that mortality rates are approximately ten times
higher amongst HIV-positive people, it is likely that fewer
misclassiﬁcations would be made based principally on
diagnostic results from up to three years prior to death as
compared with hospital records. We estimate 5% misclassi-
ﬁcation of AIDS/non-AIDS deaths. Although any misclassiﬁ-
cation is not ideal in a gold standard, we argue that this level
of misclassiﬁcation compares favourably with hospital re-
cords in this setting and, importantly, provides a quantiﬁca-
tion of the level of misclassiﬁcation which is impossible in
most hospital-based studies. In the worst-case scenario, where
all misclassiﬁcations in the gold standard are misclassiﬁed by
the algorithm, we would expect a drop in the sensitivity to
about 71% (down from 76%) and speciﬁcity to about 62%
(down from 66%).
Incorrect classiﬁcation of HIV status at baseline would
affect the validity of the gold standard. However, the
probability of misclassiﬁcation due to incorrect testing status
is very low, given the 99.6% sensitivity and speciﬁcity of the
HIV dipstick test [14]. Likewise, the probability of serocon-
version, progression to AIDS, and death within the follow-up
period of three years is vanishingly small [21,32]. Although
examination of the level of missing data and the proportion
correctly classiﬁed by interview and respondent character-
istics revealed no clear limitations, the problems of recall and
quality of responses may remain difﬁcult to quantify or detect.
Longer recall has not been associated with lower sensitivity or
speciﬁcity in validation studies, although work is needed to
deﬁne the optimal and acceptable recall period [33].
Verbal autopsy is potentially an important way in which
population levels and trends in AIDS-speciﬁc mortality can
be monitored. The data can be collected as part of developing
vital registration systems, sample vital registration systems
[34], and local demographic surveillance systems. The data-
derived set of criteria based on the history of eight signs and
symptoms can be applied for surveillance of AIDS-related
mortality in sub-Saharan Africa and other countries with
generalized AIDS epidemics. These criteria should be further
validated in time, with future data from this cohort, and
place, through application to other settings in the region.
Supporting Information
Dataset S1. Spreadsheet for Calculating Prevalence of AIDS Deaths
and HIV
Found at DOI: 10.1371/journal.pmed.0030312.sd001 (37 KB DOC).
Protocol S1. Verbal Autopsy Questionnaire
Found at DOI: 10.1371/journal.pmed.0030312.sd002 (148 KB PDF).
Protocol S2. Statistical Appendix
Found at DOI: 10.1371/journal.pmed.0030312.sd003 (18 KB DOC).
Table 3. Proportion of Deaths Correctly Classified as AIDS or Non-AIDS Stratified by Characteristics of the Deceased, the Respondent,
and Timing of the VA Relative to the Death
Variable Categorya Correctly
Classified
Total
Responses
Proportion
Correctly Classified
Interviewer A 66 91 73%
B 93 144 65%
C 92 116 79%
D–F 22 29 76%
Months between death and interview 0–11 84 116 72%
12–23 96 124 77%
24–35 84 119 71%
Relationship of respondent to deceased Husband or wife 49 73 67%
Father or mother 37 51 73%
Son or daughter 51 65 78%
Other relative 112 156 72%
Non-relative 24 30 80%
Was respondent the primary caregiver? No 148 201 74%
Yes 125 180 70%
Sex of respondent Male 127 172 74%
Female 146 204 72%
Gender of deceased Male 126 170 74%
Female 147 205 72%
Side of family of respondent Paternal 69 99 70%
Maternal 102 140 73%
Spouse 51 69 74%
Other 42 52 81%
Total 74%
aA–F represents a different member of the research team who conducted the verbal autopsy interview.
DOI: 10.1371/journal.pmed.0030312.t003
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Table S1. Table of All Signs and Symptoms and Their Relationships
with AIDS Deaths
Abbreviations: D, disease; FN, false negative; FP, false positive; LRþ,
likelihood ratio when sign/symptom is present; Se, sensitivity; Sp,
speciﬁcity; T, test; TN, true negative; TP, true positive; uOR,
unadjusted odds ratio.
Found at DOI: 10.1371/journal.pmed.0030312.st001 (198 KB DOC).
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Editors’ Summary
Background. The worldwide epidemic of HIV/AIDS is at its most severe
in poor countries—for example, in Africa, where over 25 million people
are estimated to have been infected with HIV. Such countries generally
lack the kind of health system that is able to record the cause of death
for each person who dies. This makes it very hard to know the number of
people whose deaths are related to AIDS. The uncertainty over the AIDS
death rates in these countries causes many problems. For example, it will
be hard to establish how effective the introduction of AIDS treatment
drugs is proving to be in reducing the number of AIDS deaths. A new
approach is needed to determine and record the causes of deaths in
these countries. It is not enough to rely on knowing whether the person
who has died has been found to be HIV positive; many people in poor
countries who have AIDS have never been tested, and, in any case, the
cause of death in a person with HIV may not necessarily be related to the
virus.
Why Was This Study Done? The researchers wanted to investigate the
use of the technique called ‘‘verbal autopsy.’’ This involves asking those
who were with the deceased person before they died—usually close
family members—a series of standard questions about the symptoms
the person had. This is now a recognized technique, but the researchers
wanted to know specifically how effective it can be in identifying AIDS as
the cause of death. It is also important to ‘‘validate’’ the set of questions
chosen to be used in a verbal autopsy, to see how likely they are to
produce the correct explanation for the cause of death.
What Did the Researchers Do and Find? The researchers drew up a list
of what they considered appropriate questions and used them in
interviews (conducted by nurses) with the caregivers of 381 adults who
died between 1998 and 2003 in Manicaland, a rural area of eastern
Zimbabwe. For all of these people, it was known whether they were HIV
positive or HIV negative. (This information is not known for most deaths
in rural Zimbabwe.) The 282 people who were HIV positive and did not
die in an accident or during childbirth were considered by the
researchers to have died of AIDS. (They argue this was a reasonable
assumption to make, based on what is already known about death rates
in HIV-positive and HIV-negative people in Zimbabwe.)
The questions the caregivers were asked about the condition of the
person who died included whether or not they had any of the following
signs or symptoms that are common among patients with AIDS:
moderate or severe weight loss, jaundice, herpes zoster, presence of
abscesses or sores, oral candidiasis, acute respiratory tract infections, and
vaginal tumours. Explanations of what these conditions looked like were
given to the caregivers. There were also questions on the circumstances
surrounding each death. Using the answers to the questions, it was
possible in 69% of cases to make a correct decision as to whether the
death was the result of AIDS.
What Do These Findings Mean? A verbal autopsy using the signs and
symptoms selected by these authors can be used to make reasonable
estimates of the number of AIDS deaths. The authors believe that, with
the same set of questions, it might also be possible to produce estimates
of the number of people living with HIV/AIDS. Validation of the questions
used should, however, be carried out separately in each country that
adopts this technique.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/0030312.
 MedlinePlus has many pages providing information about HIV/AIDS
 Information about the global epidemic of HIV/AIDS and international
efforts to fight it can be found on the Web site of the Joint United
Nations Programme on HIV/AIDS (UNAIDS)
 Of particular relevance is UNAIDS’ country-by-country analysis of the
situation in Africa
 The World Health Organization’s pages on HIV/AIDS. A recent
discussion on verbal autopsies has been published by WHO
 The Manicaland HIV/STD Prevention Study
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